HGH Supporting Materials
Provision or Distribution of Growth Hormone for “Antiaging”- Clinical and Legal Issues
Thomas T. Perls MD, MPH; Neal R. Reisman MD, JD, FACS; S. Jay Olshansky PhD; Journal of the American Medical Association, Vol 294 (16), pp. 2086-2090
(This paper is unrelated to the research conducted in the New England Centenarian Study)
Supporting Resources
The Section of the Federal Food Drug and Cosmetic Act Stipulating Restrictions and Penalties Regarding the Distribution and Provision of HGH:
(Please go to section (e) “Prohibited distribution of human growth hormone”. Also note that in 1993, this section was redesignated as (f) and (f), pertaining to devices was redesignated as (g).)
U.S. Department of Justice Human Growth Hormone/Steroids Statutory Overview:
Title 4 (Civil) Resource Manual. United States Attorneys’ Manual. Human Growth Hormone/Steroids Statutory Overview. 1998
FDA Letter to Dr. Perls Regarding Distribution of GH for Anti-Aging:
October 2004
FDA Warning Letters:
Chappell MA, FDA Warning letter addressed to Tony Stires, Global Internet Alliance, February 18, 2004
Costello G. FDA warning letter addressed to Alan Blair and Affordable HGH.com., June 30, 2002
HGH-Related Alerts From the National Institute on Aging (NIH) and the Federal Trade Commission:
Pills, Patches, and Shots: Can Hormones Prevent Aging? National Institute on Aging Age Page. January, 2005.
“HGH” Pills and Sprays: Human Growth Hype? FTC Consumer Alert. June 8, 2005.
FTC Stops False Claims about Fountain of Youth Oral Sprays: Sprays Do Not Contain, or Cause the Body to Produce, Human Growth Hormone as Claimed. October 18, 2005.
